Rising use of GLP-1 weight-loss drugs is impacting UK food sales, with retailers noting increased demand for healthier options and smaller portions. Major chains like Tesco, Sainsbury's, Greggs, and M&S are adapting to changing consumer habits driven by these medications, which influence eating patterns and preferences.